• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchMapLight Therapeutics
    Picture of MapLight Therapeutics logo

    MPLT — MapLight Therapeutics Share News

    $8.250.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    • Market Cap
      $436.00m
    • Enterprise Value
      $131.27m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • MPLT Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    MPLT Dividends
    • MapLight Therapeutics valued at $787 million as shares jump in Nasdaq debut

      27/10/2025 15:46
    • Drug developer MapLight Therapeutics valued at $704.3 million after US IPO (updated)

      26/10/2025 22:31
    • Brief: Maplight Therapeutics Prices IPO At $17 Per Share

      26/10/2025 21:38
    • Drug developer MapLight prices US IPO at $17 per share

      26/10/2025 21:37
    Previous12Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.